Fleischner学会视觉肺气肿CT分型有助于预测当前和既往吸烟者肺气肿进展:COPDGene研究结果
基于COPDGene前瞻性队列中4166名当前或既往吸烟者,基线Fleischner学会视觉CT分型与5年间肺气肿和气体陷闭进展相关。在COPD患者中,轻度、中度和融合性肺气肿者肺密度年下降分别为4.6、6.7和6.4 g/L,均高于微量肺气肿者的2.4 g/L(P均<.001);无COPD者中轻度和中度肺气肿者分别为3.6和3.1 g/L,高于微量者的1.8 g/L(P均<.001)。
要点
- 基线CT视觉肺气肿分型可独立预测5年肺气肿进展,COPD患者中轻至融合性者肺密度下降均高于微量者。
- 无COPD的吸烟者中,基线轻度或中度肺气肿同样预示肺密度下降快于微量者。
- 视觉分型或有助于为肺气肿治疗试验筛选进展风险较高的人群。
核心结论
- 基线CT上肺实质肺气肿的视觉分型是当前或既往吸烟者(伴或不伴COPD)后续肺气肿进展的独立预测因素。
研究设计与样本
- 前瞻性COPDGene研究(ClinicalTrials.gov标识NCT02445183)纳入2008至2011年间入组的当前和既往吸烟者(伴或不伴COPD),共4166名参与者(平均年龄60岁±9,2091名[50%]男性)。
- 基线时评估Fleischner学会视觉CT评分,并行定量吸气相和呼气相CT及肺功能检查,5年后复查定量CT和肺功能。
- 统计采用线性混合模型,校正年龄、身高、性别、种族、吸烟状态和扫描仪品牌。
关键影像表现/征象
- COPD患者(1655名,40%)中,基线CT视觉存在轻度、中度和融合性肺气肿者肺密度平均下降分别为4.6 g/L±1.1、6.7 g/L±1.1和6.4 g/L±1.2(P均<.001),微量肺气肿者为2.4 g/L±1.3(P<.001)。
- 无COPD参与者中,基线CT视觉存在轻度和中度肺气肿者肺密度平均下降分别为3.6 g/L±1.0和3.1 g/L±1.6(P均<.001),微量肺气肿者为1.8 g/L±1.0(P<.001)。
诊断标准与关键数值
- 因变量为第15百分位吸气相肺密度(经肺容积校正)作为肺气肿指标,以及呼气相CT上衰减小于-856 HU的肺容积百分比作为气体陷闭指标。
临床应用与阅片要点
- 阅读吸烟者胸部CT时,可按Fleischner学会视觉分型记录肺气肿有无及程度(微量、轻度、中度、融合性),该分型与后续肺气肿进展相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The correlation between visual emphysema patterns and subsequent progression of disease may provide a way to enrich a study population for treatment trials of emphysema. Purpose To evaluate the potential relationship between emphysema visual subtypes and progression of emphysema and gas trapping. Materials and Methods Current and former smokers with and without chronic obstructive pulmonary disease (COPD) enrolled in the prospective Genetic Epidemiology of COPD (COPDGene) study (ClinicalTrials.gov identifier: NCT02445183) between 2008 and 2011 had their Fleischner Society visual CT scores assessed at baseline, quantitative inspiratory, and expiratory CT and at 5 years. They also underwent pulmonary function testing at baseline CT and at 5 years. The dependent variables were inspiratory lung density at 15th percentile (adjusted for lung volume) as a measure of emphysema and percentage of lung volume with attenuation less than -856 HU at expiratory CT as a measure of air trapping. Statistical analysis used a linear mixed model, adjusted for age, height, sex, race, smoking status, and scanner make. Results A total of 4166 participants (mean age, 60 years ± 9 [standard deviation]; 2091 [50%] men) were evaluated. In participants with COPD (1655 participants, 40%), those with visual presence of mild, moderate, and confluent emphysema at baseline CT showed a mean decline in lung density of 4.6 g/L ± 1.1 (P < .001), 6.7 g/L ± 1.1 (P < .001), and 6.4 g/L ± 1.2 (P < .001), respectively, compared with 2.4 g/L ± 1.3 (P < .001) for those with trace emphysema. For participants without COPD, those with visual presence of mild and moderate emphysema at baseline CT showed a mean decline in lung density of 3.6 g/L ± 1.0 (P < .001) and 3.1 g/L ± 1.6 (P < .001), respectively, compared with 1.8 g/L ± 1.0 (P < .001) for those with trace emphysema. Conclusion The pattern of parenchymal emphysema at baseline CT was an independent predictor of subsequent progression of emphysema in participants who are current or former cigarette smokers with and without chronic obstructive pulmonary disease. © RSNA, 2020 Online supplemental material is available for this article.
引用
- El Kaddouri B, Strand MJ, Baraghoshi D, et al. Fleischner Society Visual Emphysema CT Patterns Help Predict Progression of Emphysema in Current and Former Smokers: Results from the COPDGene Study. Radiology. 2020. PMID: 33320065. doi:10.1148/radiol.2020200563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。